Sponsored by:
Department of Medicine
Temerty Faculty of Medicine
University of Toronto and
Princess Margaret Cancer Centre

Princess Margaret Cancer Centre’s Multiple Myeloma Day presents the latest developments in the management of myeloma and related plasma cell disorders. Guest speakers from oncology, hematology, and pharmacology shares updates in new clinical trials, available therapies, advancements in imaging, and more.

Target Audience

Community health practitioners including physicians, nurses, pharmacists, trainees, and other health care providers who are involved in the care of patients with plasma cell disorders will find this program of benefit.

Accreditation

Royal College of Physicians and Surgeons of Canada – Section 1
This event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada, approved by Continuing Professional Development, Temerty Faculty of Medicine, University of Toronto. You may claim a maximum of 5.5 hours (credits are automatically calculated).

American Medical Association – AMA PRA Category 1 Credit™ Designation
Through an agreement between the Royal College of Physicians and Surgeons of Canada and the American Medical Association, physicians may convert Royal College MOC credits to AMA PRA Category 1 Credits™. Information on the process to convert Royal College MOC credit to AMA credit can be found at: https://www.ama-assn.org/education/ama-pra-credit-system/agreement-royal-college-physicians-surgeons-canada

European Union for Medical Specialists (UEMS)
Live educational activities recognized by the Royal College of Physicians and Surgeons of Canada as Accredited Group Learning Activities (Section 1) are deemed by the European Union of Medical Specialists (UEMS) eligible for ECMEC®.


Accreditation Letters: Attendees must attend the live delivery of the education program, in-person and/or synchronously online, in order to receive their letter of accreditation or claim hours.